Anti-craving compounds for ethanol: New pharmacological tools to study addictive processes

Trends in Pharmacological Sciences

Volumn 18, Issue 2, 1997, Pages 54-59

  Spanagel, Rainer ^a   Zieglgänsberger, Walter ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL; CALCIUM CHANNEL; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE; OPIATE RECEPTOR;

ADAPTATION; ADDICTION; ALCOHOLISM; ANIMAL MODEL; BRAIN REGION; CALCIUM CURRENT; DRUG MECHANISM; EUROPE; HUMAN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REGISTRATION; REINFORCEMENT; RELAPSE; REVIEW; UNITED STATES;

EID: 0031081578     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(97)89800-8     Document Type: Review

References (62)

1. 1 Hyman, S. E. and Nestler, E. J. (1996) Am. J. Psychiatry 153, 151-162
2. 2 Altman, J. et al. (1996) Psychopharmacology 125, 285-345
3. 3 Stolerman, I. (1992) Trends Pharmacol. Sci. 13, 170-176
4. 4 Wise, R. A. (1988) J. Abnorm. Psycho. 97, 118-132
5. 5 Childress, A. R. et al. (1993) NIDA Res. Monograph 137, 73-95
6. 6 O'Brien, C. P., Childress, A. R., McLellan, A. T. and Ehrman, R. (1993) Ann. New York Acad. Sci. 654, 400-416
7. 7 Lhuintre, J-P. et al. (1985) Lancet 1, 1014-1016
8. 8 Lhuintre, J-P. et al. (1990) Alcohol Alcohol. 25, 613-622
9. 9 Sass, H., Soyka, M., Mann, K. and Zieglgänsberger, W. (1996) Arch. Gen. Psychiatry 53, 673-680
10. 10 Whitworth, A. B. et al. (1996) Lancet 347, 1438-1442
11. 11 Boismare, F. et al. (1984) Pharmacol. Biochem. Behav. 21, 787-789
12. 12 Le Magnen, J., Tran, G., Durlach, J. and Martin, C. (1987) Alcohol 4, 97-102
13. 13 Rassnick, S. et al. (1992) Ann. New York Acad. Sci. 654, 502-505
14. 14 Spanagel, R., Hölter, S. M., Allingham, K., Landgraf, R. and Zieglgänsberger, W. (1996) Eur. J. Pharmacol. 305, 38-44
15. 15 Wolffgramm, J. and Heyne, A. (1995) Behav. Brain Res. 70, 77-94
16. 16 Sinclair, J. D. and Li, T-K. (1989) Alcohol 6, 505-509
17. 17 Le Magnen, J., Tran, G. and Durlach, J. (1987) Alcohol 4, 103-108
18. 18 Spanagel, R., Zieglgänsberger, W. and Hundt, W. (1996) Eur. J. Pharmacol. 305, 51-56
19. 19 Grant, K. A. and Woolverton, W. L. (1989) Pharmacol. Biochem. Behav. 32, 607-611
20. 20 Gewiss, M., Heidebreder, C., Opsomer, L., Durbin, Ph. and DeWitte, Ph. (1991) Alcohol Alcohol. 26, 129-137
21. 21 Spanagel, R., Putzke, J., Stefferl, A., Schöbitz, B. and Zieglgänsberger, W. (1996) Eur. J. Pharmacol. 305, 45-50
22. 22 Baldo, B. A. et al. (1995) Soc. Neurosci. Abstr. 21, 1701
23. 23 Diana, M., Pistis, M., Carboni, S., Gessa, G. L. and Rossetti, Z. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 7966-7969
24. 24 Rossetti, Z. L. and Carboni, S. (1995) Eur. J. Pharmacol. 283, 177-183
25. 25 Dahchour, A., Durbin, Ph. and De Witte, Ph. (1996) Alcohol Clin. Exp. Res. 20, 93
26. 26 Littleton, J. (1995) Addiction 90, 1179-1188
27. 27 Putzke, J., Spanagel, R., Tölle, T. R. and Zieglgänsberger, W. (1996) Eur. J. Pharmacol. 317, 39-48
28. 28 Daoust, M. et al. (1992) Pharmacol. Biochem. Behav. 41, 669-674
29. 29 Zieglgänsberger, W. et al. (1996) in Acamprosate in Relapse Prevention of Alcoholism (Soyka, M., ed.), pp. 65-70, Springer
30. 30 Zeise, M. L., Kasparov, S., Capogna, M. and Zieglgänsberger, W. (1993) Eur. J. Pharmacol. 231, 47-52
31. 31 Madamba, S. G., Schweitzer, P., Zieglgänsberger, W. and Siggins, G. R. (1996) Alcohol Clin. Exp. Res. 20, 651-658
32. 32 al-Qatari, M. and Littleton, J. M. (1995) Alcohol Alcohol. 30, 550
33. 33 al-Qatari, M. and Littleton, J. M. (1996) Alcohol Clin. Exp. Res. 20, 92
34. 34 Herz, A. (1997) Psychopharmacology 129, 99-111
35. 35 Grisel, J. E., Grahame, N. J., Mogil, J. S., Belknap, J. K. and Low, M. J. (1995) Soc. Neurosci. Abstr. 21, 1699
36. 36 Gianoulakis, C., Krishnan, B. and Thavundayil, J. (1996) Arch. Gen. Psychiatry 53, 250-257
37. 37 Altshuler, H. L., Phillips, P. E. and Feinhandler, D. A. (1980) Life Sci. 26, 679-688
38. 38 Ulm, R. R., Volpicelli, J. R. and Volpicelli, L. A. (1995) J. Clin. Psychiatry 56, 5-14
39. 39 Volpicelli, J. R., Alterman, A. I., Hayashida, M. and O'Brien, C. P. (1992) Arch. Gen. Psychiatry 49, 876-880
40. 40 O'Malley, S. S. et al. (1992) Arch. Gen. Psychiatry 49, 881-887
41. 41 O'Malley, S. S. et al. (1996) Arch. Gen. Psychiatry 53, 217-224
42. 42 Sinclair, J. D. (1990) Ann. Med. 22, 357-362
43. 43 Spanagel, R., Herz, A. and Shippenberg, T. S. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 2046-2050
44. 44 Johnson, S. W. and North, R. A. (1992) J. Neurosci. 12, 483-492
45. 45 Zieglgänsberger, W., French, E. D., Siggins, G. R. and Bloom, F. E. (1979) Science 205, 415-417
46. 46 Widdowson, P. S. and Holman, R. B. (1992) J. Neurochem. 59, 157-163
47. 47 Benjamin, D., Grant, E. R. and Pohorecky, L. A. (1993) Brain Res. 621, 137-140
48. 48 Heyser, C. J., Roberts, A. J., Schulteis, G., Hyytiä, P. and Koob, G. F. (1995) Soc. Neurosci. Abstr. 21, 1698
49. 49 Ludwig, A. M., Wikler, A. and Stark, L. H. (1974) Arch. Gen. Psychiatry 30, 539-547
50. 50 Stewart, J., De Wit, H. and Eikelboom, R. (1984) Psychological Rev. 91, 251-268
51. 51 Magnan, J., Patterson, S. J., Tavani, A. and Kosterlitz, H. W. (1982) Naunyn Schmiedeberg's Arch. Pharmacol. 319, 197-205
52. 52 Tölle, T. R. et al. (1994) Neuroscience 58, 305-321
53. 53 Samson, H. H. and Harris, R. A. (1992) Trends Pharmacol. Sci. 13, 206-211
54. 54 Tabakoff, B. and Hoffman, P. L. (1996) Neuron 16, 909-912
55. 55 Ortiz, J. et al. (1995) Synapse 21, 289-298
56. 56 Trevisan, L. et al. (1994) J. Neurochem. 62, 1635-1638
57. 57 Lovinger, D. M. (1995) J. Pharmacol. Exp. Ther. 274, 164-172
58. 58 Sucher, N. J., Awobuluyi, M., Choi, Y-B. and Lipton, S. A. (1996) Trends Pharmacol. Sci. 17, 348-355
59. 59 Littleton, J. M. and Little, H. J. (1994) Addiction 89, 1397-1412
60. 60 Hölter, S. M., Danysz, W. and Spanagel, R. (1996) Eur. J. Pharmacol. 314, 1-2
61. 61 Kiianmaa, K., Hoffman, P. L. and Tabakoff, B. (1983) Psychopharmacology 79, 291-294
62. 62 Spanagel, R. (1996) Pharmacol. Biochem. Behav. 54, 645-649